The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans

In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Health Literacy Month

Celebrating Health Literacy Month 2024:

October is Health Literacy Month, a reminder of the...

A Guide to Creating a Robust Patient Engagement Strategy

Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...
patient influencers

How Patient Influencers Can Amplify the Pharma Voice

Learn more about patient influencers and their reach and relevance and how you can apply...

Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward

Ensuring that your organization embraces DE & I training is important for cultivating a strong...
people-forming-a-chain

Why Is It Important to Include Patients as Peer Reviewers

Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...
Medication without Harm

World Patient Safety Day 2022 – Medication Without Harm

Medication use around the world has increased in the last few years; a 2019 CDC...

Learn more ABOUT our company.